📑Reto slimibu medikamentu iepirkums.
Procurement process summary
This process is to purchase Reto slimibu medikamentu iepirkums.
This contract was awarded by 🇱🇻 VSIA "Bērnu klīniskā universitātes slimnīca" for an amount of EUR 292,772 to 1 supplier. It was published on 2013-11-02 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇱🇻 VSIA "Bērnu klīniskā universitātes slimnīca" Buying unitnot reported Publication date2013-11-02 Contest statusnot reported DescriptionReto slimibu medikamentu piegade.Awards
This award was granted to SIA “Tamro” by VSIA "Bērnu klīniskā universitātes slimnīca" for an amount of EUR 292,772. The procurement process was conducted through open for the category of goods. The award was granted on 2014-02-19. This is award number 1.
| Supplier | Amount | Award date | Award number |
|---|---|---|---|
| 🇱🇻 SIA “Tamro” | EUR 292,772 | 2014-02-19 | 1 |
Market context and opportunities
The execution of this contract allows the entity VSIA "Bērnu klīniskā universitātes slimnīca" to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberLV_ocds-70d2nz-7a85c914-5c2b-44fd-a5c6-b1114cb29ea4-award-1Publication date2013-11-02Contract datenot reportedAward date2014-02-19CategoriesgoodsPurchase modalityopenMethod detailspt_openStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
